These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 3933272

  • 1. Detection of beta-lactamase activity with nitrocefin of multiple strains of various microbial genera.
    Uri JV.
    Acta Microbiol Hung; 1985; 32(2):133-45. PubMed ID: 3933272
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Antimicrobial susceptibility and beta-lactamase producibility of bacteria clinically isolated during the period from December 1999 to February 2000].
    Abe M, Takaichi F, Amano H, Tazawa S, Satoh T, Nishizawa M, Takagi T, Miyamoto T.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():54-64. PubMed ID: 12599529
    [Abstract] [Full Text] [Related]

  • 4. [Antimicrobial susceptibility and beta-lactamase productivity of recent clinical isolates during the period between December 1999 and February 2000].
    Notake S, Nakamura Y, Yanagisawa H, Haketa M, Ide K, Nagai K, Kakegawa J, Shiozawa J, Kobayashi S, Shimazaki Y, Naitoh M, Toda K, Fujiki K, Okimura Y, Okabe T.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():111-8. PubMed ID: 12599534
    [Abstract] [Full Text] [Related]

  • 5. beta-Lactamase stability of some cephalosporins.
    Coppi G.
    Ital J Biochem; 1984 Sep; 33(4):280A-285A. PubMed ID: 6439674
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detection of beta lactamase producing bacteria by Cefinase: comparison with three other methods.
    Qadri SM, Perryman F, Flournoy DJ, de Silva MI.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Nov; 255(4):489-93. PubMed ID: 6419492
    [Abstract] [Full Text] [Related]

  • 8. [Antimicrobial susceptibility and prevalence of beta-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000].
    Nakasone I, Onaga S, Fukunaga H, Saitoh H, Yamane N, Sato Y.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():95-110. PubMed ID: 12599533
    [Abstract] [Full Text] [Related]

  • 9. [Drug sensitivity and beta-lactamase producibility of various types of bacteria clinically isolated during the period from December 1999 to February 2000].
    Hashimoto K, Kinosita C, Yoshinaga H, Sonda Y, Itoyama T, Oyamada K, Kajimura K, Kondou M, Sagawa K, Ouno T, Kawamoto K, Souda K, Hara K, Kakihara M, Tanaka T, Ryutou M, Shichiji A, Nakashima K, Ishibashi K, Tabira R, Yamamoto S, Nishida M, Tsutsumi Y.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():86-94. PubMed ID: 12599532
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I, Geiss HK, Mack D, Stürenburg E, Seifert H.
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beta-lactamase in gram-negative rods: the relationship between penicillinase and R plasmids in gram-negative rods.
    Takesue Y, Yokoyama T, Kodama T, Murakami Y, Sewake H, Miyamoto K, Imamura Y, Tsumura H, Matsuura Y.
    Hiroshima J Med Sci; 1990 Sep; 39(3):65-9. PubMed ID: 2126540
    [Abstract] [Full Text] [Related]

  • 14. [Antimicrobial susceptibility and beta-lactamase types among clinical isolates during January and February 2000 in the Kinki area of Japan].
    Yamasaki K, Nishio H, Komatsu M, Satoh K, Yamashita T, Washidu R, Shimakawa K, Kinoshita S, Ura T, Aihara M.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():65-78. PubMed ID: 12599530
    [Abstract] [Full Text] [Related]

  • 15. Diversity of beta-lactamase activity among clinical isolates of gram-negative bacilli.
    Farrar WE, Newsome JK.
    Am J Clin Pathol; 1976 Apr; 65(4):570-4. PubMed ID: 817594
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH, Chuang YC, Yu WL.
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM.
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [Abstract] [Full Text] [Related]

  • 18. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z, Zhu D, Zhang Y, Wang F.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1476-9. PubMed ID: 12509910
    [Abstract] [Full Text] [Related]

  • 19. [Detection of hyperproduction of chromosomal beta-lactamase in strains of Escherichia coli, Enterobacter cloacae and Pseudomonas aeruginosa].
    Roy C, Tirado M, Segura C, Esteva C, Teruel D.
    Enferm Infecc Microbiol Clin; 1989 Nov 10; 7(6):301-6. PubMed ID: 2518766
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria.
    Stürenburg E, Lang M, Horstkotte MA, Laufs R, Mack D.
    J Antimicrob Chemother; 2004 Nov 10; 54(5):870-5. PubMed ID: 15471997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.